T1	Outcomes 0 18	Cost-effectiveness
T2	Outcomes 1868 1923	severity of depressive symptoms, according to the PHQ9.
T3	Outcomes 1955 2006	remission as measured with the PHQ9 and the IDS-SR,
T4	Outcomes 2011 2078	cost-effectiveness measured with the TiC-P, the EQ-5D and the SF-36